| Bioactivity | C16 Galactosylceramide is a sphingolipid compound. C16 Galactosylceramide participates in the physiological processes of lipid metabolism and immune regulation in cells. C16 Galactosylceramide can be used in the study of diabetes[1]. |
| CAS | 34324-89-5 |
| Formula | C40H77NO8 |
| Molar Mass | 700.04 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Buschard K, et al. Involvement of sulfatide in beta cells and type 1 and type 2 diabetes. Diabetologia. 2005 Oct;48(10):1957-62. |
C16 Galactosylceramide
CAS: 34324-89-5 F: C40H77NO8 W: 700.04
C16 Galactosylceramide is a sphingolipid compound. C16 Galactosylceramide participates in the physiological processes of
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.